glp-1 receptor antagonist GLP-1R 1 | GLP-1R Antagonist GLP-1 receptor agonists in the

Retrieved 10 February 2026

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

Retrieved 17 April 2026

This article examines Remedy Meds Review's model and how compounded alternatives with genetic insights may support more targeted provider conversations

Key Takeaways The FDA recently approved Zepbound as a targeted therapy for obstructive respiratory conditions

(Lausanne) 12 , 721135 (2021)